Loading...
OTC Markets
Totals
Securities
12,305
Dollar Vol
$2.2B
Share Vol
4.4B
Trades
358,966

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

RDGL
Vivos Inc.

Common Stock

0.11

-0.0039

-3.42%

No Inside Bid / Offer

Real-Time Best Bid & Ask: 07:06am 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/10/2025

0.1139

0.1068 - 0.1188

261,659

Market Cap calculated only for this class of securities.

50,213,413

Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Vivos Inc. Company Logo
Vivos Inc developed a Y-90 brachytherapy product called Precision Radionuclide TherapyTM. It is designated as "Breakthrough" by the FDA. There is an ongoing clinical trial in humans in India and multiply animal therapies for horses, dogs, cats, and exotics in a growing number of certified clinics across the United States.
Videos
OTCQB Venture Market Logo
Joined OTCQB 09/2019
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.